SQNM hot and heavy action in the pre-market. Price target raised to $16 @ Cantor Fitzgerald...
Cantor Fitzgerald upgraded Sequenom after meeting with the company's management, as the firm thinks that the development of the company's molecular diagnostics portfolio is back on track. The firm thinks the company's pipeline appears to be progressing and it set a $16 target. :theflyonthewall.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.